Policy Issues Affecting Patient Access to Approved Therapies in Myeloma
June 2019
Shared Decision Making: Insights from Rheumatoid Arthritis Patients in Europe
May 2019
June 2019
May 2019
January 2018
September 2017
May 2017
January 2017
November 2016
November 2016
February 2016
Biologics & Biosimilars: What Matters to Physicians?
December 2017
Biologics & Biosimilars: Do Physicians Understand the Differences?
September 2016
December 2017
September 2016
September 2016
Fast Facts: 2019 European Cardiology Guidelines on Cholesterol Management
October 2019
Fast Facts: Impact of High Cholesterol
February 2019
October 2019
February 2019
October 2017
April 2017
April 2017
April 2017
April 2017
April 2017
April 2017
Rheumatoid Arthritis: Access, Policy and Advocacy Goals
October 2017
The Role of Drug Donations in Expanding Access to Medicines (Disponible en español)
August 2017
October 2017
August 2017
September 2016
5 Policy Principles to Improve Access for Patients with Rheumatoid Arthritis
October 2017
Chronic Pain in Europe
March 2017
October 2017
March 2017
How to Talk to Your Health Care Provider About Rheumatoid Arthritis
June 2019
Ver en español
Voir en français
Ver em português
Guarda in italiano
Auf deutsch ansehen
Bekijk in het Nederlands
Προβολή στα ελληνικά
हिंदी में देखें
اردو میں دیکھیں
High Cholesterol in Europe
April 2019
Sign up to receive updates from GAfPA
Biosimilar Briefings Review Nature and Impact of Biosimilars on Access
October 1, 2019
What New Cholesterol Guidelines Mean for Patients
September 27, 2019